Axoltis Pharma’s R&D Team, will attend FENS Forum 2022, the Europe’s largest international neuroscience conference, which will take place in Paris, France, on July 9-13th, 2022. Three posters will be presented, demonstrating the potential of our drug-candidate NX210cfor neurological pathologies.